Clinical Trials Directory

Trials / Terminated

TerminatedNCT04607135

ARFI Imaging for Targeted Prostate Biopsy

Acoustic Radiation Force Impulse (ARFI) Imaging for Targeted Prostate Biopsy

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Duke University · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate a new ultrasound technique. This technique may provide additional and improved information about the stiffness and sizes of the internal structures of your prostate in order to improve the guidance for a targeted biopsy. The investigational, custom-designed probe and needle guide will be used to produce images of your prostate and provide guidance for up to 4 additional biopsy samples (cores) prior to a standard magnetic resonance (MR) ultrasound fusion biopsy procedure. Above the time required for the MR ultrasound fusion biopsy, this study will take up to 30 additional minutes of time for collection of the investigational device guided collection of biopsy samples Risks of participation include increased time under anesthesia (to collect additional biopsies) and slight heating of tissue.

Conditions

Interventions

TypeNameDescription
DEVICEAcoustic radiation force impulse (ARFI)Sound waves are sent in a series and are expected to "push on" the prostate and move it a very small amount (the width of a hair). The stiffer the structure (prostate), the less it will move. This motion will be detected by the ultrasound system
DEVICEUltrasoundStandard ultrasound imaging session, ultrasound sound waves are sent into the tissue and bounce off of structures to make an image that appears on a screen

Timeline

Start date
2021-10-22
Primary completion
2023-03-28
Completion
2023-03-28
First posted
2020-10-29
Last updated
2025-05-06
Results posted
2024-01-05

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04607135. Inclusion in this directory is not an endorsement.